Publication | Open Access
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial
150
Citations
22
References
2022
Year
Translational MedicineAntifungal AgentAntifungal AgentsRezafungin Versus CaspofunginRandomised Phase 3PharmacologyClinical MycologyInvasive CandidiasisMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1